查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2044485

2034年醫療保健產業ESG市場預測：按ESG組成部分、交付方式、實施方式、最終用戶和地區分類的全球分析

ESG in Healthcare Market Forecasts to 2034 - Global Analysis By ESG Component (Environmental Solutions, Social Impact Solutions, and Governance & Compliance Solutions), Offering, Deployment Mode, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫療保健產業的 ESG 市場規模將達到 211 億美元，並在預測期內以 7.6% 的複合年成長率成長，到 2034 年將達到 380 億美元。

在醫療保健領域，ESG指的是將環境、社會和管治標準融入醫療機構（例如醫院、製藥公司和醫療設備製造商）的營運、策略和報告中。該市場旨在滿足日益成長的對永續醫療保健實踐的需求，涵蓋從減少碳排放和醫療廢棄物到確保患者公平獲得醫療服務以及透明的公司企業管治等各個方面。隨著監管機構、投資者和患者越來越關注醫療保健更廣泛的社會影響，ESG解決方案對於整個行業的風險管理、合規性和長期價值創造變得至關重要。

投資者和監管機構對永續醫療保健營運的壓力日益增大

金融機構和政府機構日益要求醫療機構揭露環境、社會和治理（ESG）指標，並將資金籌措和還款率與永續發展績效掛鉤。大型資產管理公司現在已將ESG評分納入其投資決策，迫使醫院網路和大型製藥企業製定可衡量的環境和社會目標。同時，歐盟和北美的監管機構也強制要求醫療機構報告溫室氣體排放情況，並對供應鏈進行人權侵犯的實質審查。這種雙重壓力為專門的ESG解決方案創造了強力的商業理由，因為未能展現進展的醫療機構將面臨不斷上升的借貸成本、監管處罰以及機構投資者信心的喪失。

實施成本高且缺乏標準化的ESG指標

許多醫療機構，尤其是小規模診所和地方醫院，難以證明建構完善的ESG基礎設施（包括軟體平台、資料收集系統和諮詢合約）所需的初步投資的合理性。醫療保健子部門缺乏普遍接受的ESG報告標準，進一步加劇了實施難度，因為醫療服務提供者不清楚應該追蹤哪些指標以及如何進行績效評估。 GRI、SASB和TCFD等不同的框架增加了管理負擔，而整合來自傳統IT系統的ESG資料也增加了技術複雜性。這些財務和營運障礙減緩了市場滲透，尤其是在醫療預算有限的發展中地區。

ESG與數位醫療轉型舉措的整合

隨著全球醫療系統透過電子健康記錄、遠端醫療和人工智慧診斷加速數位轉型，ESG（環境、社會和治理）因素可以無縫融入這些技術投資中。基於雲端的ESG平台可以利用來自能源管理系統、採購資料庫和病患滿意度調查的現有資料流，實現報告自動化並識別改進機會。數位醫療與ESG的整合能夠提高跨職能效率，並降低與永續發展措施相關的額外成本。率先將ESG融入其數位化藍圖的企業，可以透過降低營運成本、提升品牌聲譽以及更好地應對新的監管要求來獲得競爭優勢，從而為整合解決方案供應商開闢巨大的市場機會。

醫療保健產業面臨「綠色清洗」指控，相關人員也對此表示懷疑。

醫療保健行業歷來資源消耗和廢棄物產生量巨大，因此其環境和社會責任聲明正受到嚴格審查。一些行銷手段誇大永續舉措，例如略微減少塑膠包裝，卻忽略藥品造成的污染，一旦被揭穿，後果不堪設想。患者權益組織、舉報人和調查記者數量不斷增加，社群媒體上的宣傳活動能夠迅速損害機構的信譽。出於對聲譽受損的擔憂，一些醫療保健領導者在公開承諾實現環境、社會和治理（ESG）目標時猶豫不決，謹慎漸進的做法越來越受歡迎，這減緩了高透明度報告解決方案的普及，並限制了綜合性ESG軟體的市場成長。

新冠疫情的感染疾病：

新冠疫情暴露了供應鏈、員工韌性和廢棄物管理流程中的關鍵脆弱性，大大改變了醫療保健產業的ESG（環境、社會和治理）優先事項。一次性個人防護工具和疫苗相關耗材的激增加劇了人們對環境的擔憂，而員工倦怠和健康差距等社會問題也日益凸顯。為此，醫療保健產業經營團隊加快了ESG投資步伐，將其從自願性舉措轉變為策略性要求。世界各國政府紛紛推出與疫情相關的專款，以改善環境和社會指標為條件。此次危機也推動了遠距ESG評估和虛擬諮詢的普及，永久降低了軟體解決方案的進入門檻，並將市場拓展至先前對此類服務持謹慎態度的醫療保健產業。

在預測期內，環境解決方案產業預計將佔據最大的市場佔有率。

在預測期內，環境解決方案領域預計將佔據最大的市場佔有率。這主要是由於醫療保健產業龐大的碳足跡和廢棄物產生量。醫院24小時運轉，消耗大量能源用於暖氣、冷氣、照明和醫療設備，同時每年產生數百萬噸廢棄物、廢棄物和危險廢棄物。監管機構正在收緊排放限制和廢棄物處理要求，迫使醫療保健機構投資於節能基礎設施、可再生能源、廢棄物分類技術和永續供應鏈管理。降低能源成本和減少廢棄物帶來的即時經濟效益進一步強化了其商業價值，確保環境解決方案在整個預測期內主導ESG（環境、永續）領域。

預計在預測期內，ESG數據分析服務領域將呈現最高的複合年成長率。

在預測期內，受醫療機構迫切需要準確衡量、評估和提升其ESG績效的驅動，ESG數據分析服務領域預計將呈現最高的成長率。來自能源計量表、採購系統和患者調查的原始數據必須透過碳核算、社會影響評分和管治風險評估等高階分析方法轉化為可執行的洞察。利用機器學習模型可以識別潛在的排放熱點，並在供應鏈脆弱性影響患者照護之前對其進行預測。隨著報告框架的不斷演變和投資者需求的日益成長，醫療機構擴大選擇外包專業分析工作，而不是建立內部能力，這導致對能夠提供符合審計要求的洞察和具有競爭力的基準分析的第三方資訊服務的需求激增。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這得益於嚴格的監管要求、積極的股東倡導以及關鍵醫療保健系統的集中。美國證券交易委員會 (SEC)提案的氣候變遷資訊揭露規則，以及各州層級的醫療保健永續發展義務，正在塑造一個以合規主導的市場。大規模綜合醫療保健網路和製藥公司擁有專門的 ESG 團隊和充足的預算，從而能夠儘早採用綜合解決方案。加拿大的醫療保健永續發展舉措也扮演了進一步的角色。領先的 ESG 軟體供應商和顧問公司總部設在該地區，確保了持續的創新和本地支持，從而鞏固了北美在整個預測期內的主導地位。

複合年成長率最高的地區：

在預測期內，歐洲地區預計將呈現最高的複合年成長率。這主要得益於歐盟開創性的「企業永續發展報告指令」以及「歐洲綠色交易」中針對醫療保健產業的具體規定。歐盟成員國強制要求所有大型醫院和醫療保健相關企業披露環境、社會和治理（ESG）訊息，而具有法律約束力的截止日期正在加速技術的應用。該地區健全的公共醫療保健體系能夠協調國家網路間的永續性舉措，從而為ESG解決方案供應商創造規模經濟效益。此外，ESG標準在歐洲醫療保健採購競標中的重要性日益凸顯，要求供應商證明其符合相關規定。這種監管上的領先地位，加上歐洲公民高度的環保意識，使歐洲成為醫療保健ESG市場成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰和機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫療保健產業ESG市場：依ESG組成部分分類

  • 環境解決方案
  • 社會影響解決方案
  • 管治與合規解決方案

第6章：全球醫療保健產業ESG市場：依產品/服務分類

  • ESG軟體平台
  • 諮詢和顧問服務
  • ESG 資料與分析服務

第7章：全球醫療保健產業的ESG市場：依部署模式分類

  • 現場
  • 基於雲端的

第8章：全球醫療保健產業的ESG市場：依最終用戶分類

  • 醫院和醫療保健機構
  • 製藥和生物技術公司
  • 醫療設備製造商
  • 醫療保險公司和保險公司
  • 受託研究機構（CRO）

第9章：全球醫療保健產業的ESG市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • Johnson & Johnson
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Sanofi SA
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Medtronic plc
  • Siemens Healthineers AG
  • Philips NV
  • GE HealthCare Technologies Inc.
  • UnitedHealth Group Incorporated
  • CVS Health Corporation
Product Code: SMRC36274

According to Stratistics MRC, the Global ESG in Healthcare Market is accounted for $21.1 billion in 2026 and is expected to reach $38.0 billion by 2034 growing at a CAGR of 7.6% during the forecast period. ESG in healthcare refers to the integration of environmental, social, and governance criteria into the operations, strategy, and reporting of healthcare organizations, including hospitals, pharmaceutical companies, and medical device manufacturers. This market addresses the growing demand for sustainable healthcare practices, from reducing carbon emissions and medical waste to ensuring equitable patient access and transparent corporate governance. As regulators, investors, and patients increasingly scrutinize healthcare's broader societal impact, ESG solutions are becoming essential for risk management, compliance, and long-term value creation across the industry.

Market Dynamics:

Driver:

Rising pressure from investors and regulators for sustainable healthcare operations

Financial institutions and government bodies are increasingly requiring healthcare organizations to disclose ESG metrics, tying access to capital and reimbursement rates to sustainability performance. Major asset managers now integrate ESG scores into investment decisions, pushing hospital networks and pharmaceutical giants to adopt measurable environmental and social targets. Simultaneously, regulators in the European Union and North America are mandating greenhouse gas reporting and supply chain due diligence for human rights violations. This dual pressure creates a compelling business case for dedicated ESG solutions, as healthcare entities that fail to demonstrate progress face higher borrowing costs, regulatory penalties, and loss of institutional investor confidence.

Restraint:

High implementation costs and lack of standardized ESG metrics

Many healthcare organizations, particularly smaller clinics and regional hospitals, struggle to justify the upfront investment required for robust ESG infrastructure, including software platforms, data collection systems, and consulting engagements. The absence of universally accepted ESG reporting standards across healthcare sub-sectors further complicates adoption, as providers face confusion over which metrics to track and how to benchmark performance. Different frameworks from GRI, SASB, and TCFD create administrative burdens, while the need to integrate ESG data from legacy IT systems adds technical complexity. These financial and operational barriers slow market penetration, especially in developing regions with constrained healthcare budgets.

Opportunity:

Integration of ESG with digital health transformation initiatives

As healthcare systems worldwide accelerate digitalization through electronic health records, telemedicine, and AI-driven diagnostics, ESG considerations can be seamlessly embedded into these technology investments. Cloud-based ESG platforms can leverage existing data streams from energy management systems, procurement databases, and patient satisfaction surveys to automate reporting and identify improvement opportunities. The convergence of digital health and ESG creates cross-functional efficiencies, reducing the incremental cost of sustainability efforts. Early adopters that integrate ESG into their digital roadmaps gain competitive advantages through lower operational costs, enhanced brand reputation, and readiness for emerging regulatory requirements, opening substantial market opportunities for integrated solution providers.

Threat:

Greenwashing allegations and stakeholder skepticism in healthcare

Healthcare organizations face intense scrutiny over claims of environmental or social responsibility, given the sector's historically high resource consumption and waste generation. Exaggerated marketing about sustainable practices, such as minor reductions in plastic packaging while ignoring pharmaceutical pollution, can backfire spectacularly when exposed. Patient advocacy groups, whistleblowers, and investigative journalists are increasingly vigilant, and viral social media campaigns can rapidly damage institutional credibility. The resulting fear of reputational harm makes some healthcare leaders hesitant to publicly commit to ESG goals, slowing adoption of transparent reporting solutions and favoring cautious, incremental approaches that limit market expansion for comprehensive ESG software.

Covid-19 Impact:

The COVID-19 pandemic dramatically reshaped ESG priorities in healthcare by exposing deep vulnerabilities in supply chains, workforce resilience, and waste management protocols. Massive surges in single-use personal protective equipment and vaccine-related disposables intensified environmental concerns, while staff burnout and health inequities became front-page social issues. These revelations prompted healthcare executives to accelerate ESG investments as strategic imperatives rather than optional initiatives. Governments introduced pandemic-related funding conditional on improved environmental and social metrics. The crisis also normalized remote ESG assessments and virtual consulting, permanently reducing barriers to entry for software-based solutions and expanding the addressable market across previously hesitant healthcare segments.

The Environmental Solutions segment is expected to be the largest during the forecast period

The Environmental Solutions segment is expected to account for the largest market share during the forecast period, driven by healthcare's substantial carbon footprint and waste generation. Hospitals operate around the clock, consuming massive amounts of energy for heating, cooling, lighting, and medical equipment, while generating millions of tons of pharmaceutical, plastic, and hazardous waste annually. Regulators are imposing stricter emissions limits and waste disposal requirements, compelling healthcare providers to invest in energy-efficient infrastructure, renewable energy procurement, waste segregation technologies, and sustainable supply chain management. The immediate financial benefits of energy cost reduction and waste minimization further strengthen the business case, ensuring environmental solutions dominate the ESG component landscape throughout the forecast timeline.

The ESG Data & Analytics Services segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the ESG Data & Analytics Services segment is predicted to witness the highest growth rate, fueled by healthcare organizations' urgent need to measure, benchmark, and improve their ESG performance accurately. Raw data from energy meters, procurement systems, and patient surveys must be transformed into actionable intelligence through sophisticated analytics, including carbon accounting, social impact scoring, and governance risk assessments. Machine learning models can identify hidden emission hotspots or predict supply chain vulnerabilities before they disrupt patient care. As reporting frameworks evolve and investor demands intensify, healthcare entities are increasingly outsourcing specialized analytics rather than building in-house capabilities, creating explosive demand for third-party data services that deliver audit-ready insights and competitive benchmarking.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by stringent regulatory requirements, active shareholder advocacy, and the concentration of major healthcare systems. The U.S. Securities and Exchange Commission's proposed climate disclosure rules, combined with state-level healthcare sustainability mandates, create a compliance-driven market. Large integrated delivery networks and pharmaceutical corporations have dedicated ESG teams and substantial budgets, enabling early adoption of comprehensive solutions. Canadian healthcare sustainability initiatives further contribute. The presence of leading ESG software vendors and consulting firms headquartered in the region ensures continuous innovation and localized support, solidifying North America's dominant position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by the European Union's pioneering Corporate Sustainability Reporting Directive and the European Green Deal's specific healthcare provisions. EU member states are implementing mandatory ESG disclosures for all large hospitals and health-related companies, with binding deadlines accelerating technology procurement. The region's strong public healthcare systems enable coordinated sustainability initiatives across national networks, creating economies of scale for ESG solution providers. Additionally, European healthcare procurement is increasingly weighting ESG criteria in tenders, forcing suppliers to demonstrate compliance. This regulatory leadership, combined with high environmental awareness among European citizens, positions Europe as the fastest-growing market for ESG in healthcare.

Key players in the market

Some of the key players in ESG in Healthcare Market include Johnson & Johnson, Pfizer Inc., Roche Holding AG, Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi S.A., Abbott Laboratories, Becton, Dickinson and Company, Medtronic plc, Siemens Healthineers AG, Philips N.V., GE HealthCare Technologies Inc., UnitedHealth Group Incorporated, and CVS Health Corporation.

Key Developments:

In January 2026, Philips N.V. completed the acquisition of SpectraWAVE, integrating a "Circular Edition" portfolio approach to coronary interventional procedures to reduce medical waste.

In November 2025, Siemens Healthineers AG unveiled a new "Digital Twin" initiative designed to reduce the need for physical prototype testing, significantly lowering the carbon intensity of their R&D cycle.

In October 2025, Novartis AG confirmed a $23 billion investment in the U.S. manufacturing footprint over five years, focusing on resilient and localized supply chains to mitigate environmental risks from global logistics.

ESG Components Covered:

  • Environmental Solutions
  • Social Impact Solutions
  • Governance & Compliance Solutions

Offerings Covered:

  • ESG Software & Platforms
  • Consulting & Advisory Services
  • ESG Data & Analytics Services

Deployment Modes Covered:

  • On-Premise
  • Cloud-Based

End Users Covered:

  • Hospitals & Healthcare Providers
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Healthcare Payers & Insurance Providers
  • Contract Research Organizations (CROs)

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global ESG in Healthcare Market, By ESG Component

  • 5.1 Environmental Solutions
  • 5.2 Social Impact Solutions
  • 5.3 Governance & Compliance Solutions

6 Global ESG in Healthcare Market, By Offering

  • 6.1 ESG Software & Platforms
  • 6.2 Consulting & Advisory Services
  • 6.3 ESG Data & Analytics Services

7 Global ESG in Healthcare Market, By Deployment Mode

  • 7.1 On-Premise
  • 7.2 Cloud-Based

8 Global ESG in Healthcare Market, By End User

  • 8.1 Hospitals & Healthcare Providers
  • 8.2 Pharmaceutical & Biotechnology Companies
  • 8.3 Medical Device Companies
  • 8.4 Healthcare Payers & Insurance Providers
  • 8.5 Contract Research Organizations (CROs)

9 Global ESG in Healthcare Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Johnson & Johnson
  • 12.2 Pfizer Inc.
  • 12.3 Roche Holding AG
  • 12.4 Novartis AG
  • 12.5 Merck & Co., Inc.
  • 12.6 GlaxoSmithKline plc
  • 12.7 Sanofi S.A.
  • 12.8 Abbott Laboratories
  • 12.9 Becton, Dickinson and Company
  • 12.10 Medtronic plc
  • 12.11 Siemens Healthineers AG
  • 12.12 Philips N.V.
  • 12.13 GE HealthCare Technologies Inc.
  • 12.14 UnitedHealth Group Incorporated
  • 12.15 CVS Health Corporation

List of Tables

  • Table 1 Global ESG in Healthcare Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global ESG in Healthcare Market Outlook, By ESG Component (2023-2034) ($MN)
  • Table 3 Global ESG in Healthcare Market Outlook, By Environmental Solutions (2023-2034) ($MN)
  • Table 4 Global ESG in Healthcare Market Outlook, By Social Impact Solutions (2023-2034) ($MN)
  • Table 5 Global ESG in Healthcare Market Outlook, By Governance & Compliance Solutions (2023-2034) ($MN)
  • Table 6 Global ESG in Healthcare Market Outlook, By Offering (2023-2034) ($MN)
  • Table 7 Global ESG in Healthcare Market Outlook, By ESG Software & Platforms (2023-2034) ($MN)
  • Table 8 Global ESG in Healthcare Market Outlook, By Consulting & Advisory Services (2023-2034) ($MN)
  • Table 9 Global ESG in Healthcare Market Outlook, By ESG Data & Analytics Services (2023-2034) ($MN)
  • Table 10 Global ESG in Healthcare Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 11 Global ESG in Healthcare Market Outlook, By On-Premise (2023-2034) ($MN)
  • Table 12 Global ESG in Healthcare Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 13 Global ESG in Healthcare Market Outlook, By End User (2023-2034) ($MN)
  • Table 14 Global ESG in Healthcare Market Outlook, By Hospitals & Healthcare Providers (2023-2034) ($MN)
  • Table 15 Global ESG in Healthcare Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 16 Global ESG in Healthcare Market Outlook, By Medical Device Companies (2023-2034) ($MN)
  • Table 17 Global ESG in Healthcare Market Outlook, By Healthcare Payers & Insurance Providers (2023-2034) ($MN)
  • Table 18 Global ESG in Healthcare Market Outlook, By Contract Research Organizations (CROs) (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.